Orthobiologics

Anika Therapeutics commenced EU launch of CINGAL® viscosupplement to treat OA-related pain....

Pre-clinical study results demonstrated that BONESUPPORT’s CERAMENT™, loaded with rhBMP-2 + zoledronic acid in very low doses, was able to quantitatively/qualitatively...

NuVasive announced the U.S. launch of AttraX® Putty, a synthetic bone graft for use in the posterior lateral spine....

Vertebral Technologies launched the InterGraft™ series of 100% DBM osteoinductive scaffolds....

Bone Therapeutics is planning a Phase II trial with ALLOB® allogeneic bone cell therapy for the treatment of severe osteoporosis. ...

Anika Therapeutics announced Canada launch of CINGAL® viscosupplement, cleared to treat knee osteoarthritis pain. CINGAL will be marketed by Pendopharm....

Bone Therapeutics announced positive efficacy results for the 2nd patient cohort in its Phase I/IIA trial of ALLOB® allogeneic bone cell therapy product for the...

Orthocell was granted ethical approval in Australia for a clinical study of a microfracture technique using the Celgro SMRT Graft collagen scaffold....

Bone Therapeutics completed recruitment for its ALLOB® allogeneic cell therapy Phase IIA spinal fusion study. The company will extend the trial...

Anika Therapeutics received CE Mark approval for CINGAL® as a medical device to treat knee osteoarthritis pain. ...